Results 81 to 90 of about 120,543 (256)

Medications for management of opioid use disorder

American Journal of Health-System Pharmacy, 2019
Abstract Purpose The use of buprenorphine, methadone, and long-acting naltrexone for treatment of opioid use disorder (OUD) is discussed, including a review of current literature detailing treatment approaches and action steps to optimize treatment in acute care and office-based settings.
Patrick J. Bridgeman, Jennifer L. Koehl, David E. Zimmerman   +2 more
openaire   +3 more sources

Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy

Frontiers in Pharmacology, 2023
Scott John, David R. Walwyn, Kathryn DeFea, Tim G. Hales, Wendy Walwyn   +4 more
doaj   +1 more source

Substance Use Disorder Insurance Benefits: A Survey of State Benchmark Plans

, 2019
Professor Tovino presents the results of a survey of state benchmark health plan coverage of substance use disorder treatments and services, including treatments and services for opioid use ...
Tovino, Stacey A.
core  

Use of a Decision Aid in Medication Initiation Among Patients with Opioid Use Disorder and HIV [PDF]

, 2023
Opioid use disorder refers to the maladaptive use of prescribed or illicit opioids. This condition can be treated using pharmacotherapy referred to as medications for opioid use disorder (MOUD), but they are underutilized.
Gateley, Katrina
core   +1 more source

Former heroin-dependent alcohol use disorder patients. prevalence, addiction history and clinical features [PDF]

, 2015
Aims: To examine the prevalence of former heroin dependence (FHA) in Alcohol Use Disorder (AUD) patients; to compare the clinical characteristics of FHA-AUD patients versus AUD patients without any past use of heroin at alcohol treatment entry; to ...
Ceccanti, Mauro, Maremmani, Angelo Giovanni Icro, Maremmani, Icro, Pacini, Matteo   +3 more
core   +1 more source

Design, recruitment outcomes, and sample characteristics of the Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) trial [PDF]

, 2017
This manuscript describes the study protocol, recruitment outcomes, and baseline participant characteristics for the Strategies for Prescribing Analgesics Comparative Effectiveness (SPACE) trial.
Bair, Matthew J., DeRonne, Beth, Gravely, Amy, Jensen, Agnes C., Krebs, Erin E., Kroenke, Kurt, Leverty, David, Noorbaloochi, Siamak, Nugent, Sean, Rutks, Indulis   +9 more
core   +1 more source

Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder

Harm Reduction Journal
Background As the opioid public health crisis evolves to include fentanyl and other potent synthetic opioids, more patients are admitted to the hospital with serious complications of drug use and frequently require higher levels of care, including ...
Laura Szczesniak, Sarah Britton, Theresa Baxter RN, Ross Sullivan   +3 more
doaj   +1 more source

Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up

Harm Reduction Journal
Background Individuals with opioid use disorder (OUD) often have concurrent use of non-opioid substances. When patients enter opioid maintenance treatment (OMT), less is known about outcomes regarding the use of other types of drugs.
Endre Dahlen Bjørnestad, John-Kåre Vederhus, Thomas Clausen   +2 more
doaj   +1 more source

Confronting the opioid crisis: Practical pain management and strategies: AOA 2018 critical issues symposium [PDF]

, 2019
The United States is in the midst of an opioid crisis. Clinicians have been part of the problem because of overprescribing of narcotics for perioperative pain management.
Hsu, Joseph R, Jahangir, A Alex, Miller, Anna N, Mir, Hassan R, Obremskey, William T   +4 more
core   +1 more source

Is opioid dependency related to coping strategies? [PDF]

, 2015
Using opioid for recreational purposes has a very long history in Iran. Social influence is a useful framework in understanding how the social environment affects the individual's behavioral choices to use drugs.
Behnampour, N., Modanloo, M., Mousavi, S., Saghafi, S., Taziki, S.   +4 more
core   +1 more source